摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-叔丁基氧羰基-L-组氨酸甲酯 | 2488-14-4

中文名称
N-叔丁基氧羰基-L-组氨酸甲酯
中文别名
N-BOC-L-组氨酸甲酯;N-BOC-L-组氨酸 甲酯
英文名称
N-(tert-butoxycarbonyl)-L-histidine methyl ester
英文别名
N-α-(tert-butoxycarbonyl)-L-histidine methyl ester;Boc-L-His-OMe;N-(α)-Boc-L-histidine methyl ester;N-Boc-L-histidine methyl ester;Boc-His-OMe;methyl (2S)-2-[(tert-butoxycarbonyl)amino]-3-(1H-imidazol-4-yl)propanoate;methyl (tert-butoxycarbonyl)histidinate;methyl (2S)-3-(1H-imidazol-5-yl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoate
N-叔丁基氧羰基-L-组氨酸甲酯化学式
CAS
2488-14-4
化学式
C12H19N3O4
mdl
——
分子量
269.301
InChiKey
RWEVEEORUORBAX-VIFPVBQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    120 °C
  • 沸点:
    482.2±40.0 °C(Predicted)
  • 密度:
    1.193±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    93.3
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2933290090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    -15°C储存

SDS

SDS:ab086da005f9bca57a5dfceb525c21b2
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: Boc-His-ome
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: Boc-His-ome
CAS number: 2488-14-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C12H19N3O4
Molecular weight: 269.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

BocHisOme是组氨酸衍生物。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3

反应信息

  • 作为反应物:
    描述:
    N-叔丁基氧羰基-L-组氨酸甲酯 在 palladium on activated charcoal 、 Rh on carbon sodium hydroxide 、 Amberlite IR 45 (acetate form) 、 氢气1-羟基苯并三唑三乙胺N,N'-二环己基碳二亚胺三氟乙酸 作用下, 以 甲醇氯仿溶剂黄146N,N-二甲基甲酰胺 为溶剂, 反应 23.5h, 生成 大鼠转铁蛋白
    参考文献:
    名称:
    Brown, Tom; Jones, John H.; Richards, John D., Journal of the Chemical Society. Perkin transactions I, 1982, # 7, p. 1553 - 1562
    摘要:
    DOI:
  • 作为产物:
    描述:
    L-组氨酸氯化亚砜三乙胺 作用下, 以 甲醇 为溶剂, 反应 127.0h, 生成 N-叔丁基氧羰基-L-组氨酸甲酯
    参考文献:
    名称:
    咪唑和组氨酸衍生的交联剂的合成,类似于金和地精
    摘要:
    具有中央阳离子杂环核心(例如,咪唑鎓)的氨基酸衍生物是蛋白质和高级糖基化末端(AGE)产物的生物学相关交联剂。在此,以天冬氨酸和谷氨酸衍生的甲磺酸酯为关键步骤,通过N-烷基化由咪唑或组氨酸合成了含咪唑鎓的交联剂。进行了生物学研究以探测这些化合物的生物相容性。
    DOI:
    10.1055/s-0040-1706144
  • 作为试剂:
    描述:
    4-硝基苯基乙酸酯 在 phosphate buffer 、 N-叔丁基氧羰基-L-组氨酸甲酯 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 对硝基苯酚溶剂黄146
    参考文献:
    名称:
    Hydrolysis ofp-Nitrophenyl Esters by Histidine-containing Linear and Cyclic Peptides
    摘要:
    研究了几种含有组氨酸及其他氨基酸残基的线性和环状肽催化对硝基苯乙酸酯 (PNPA) 和对硝基苯己酸酯 (PNPH) 的水解。这些肽的催化活性低于咪唑对 PNPA 和 PNPH 的催化活性。另一方面,在阳离子表面活性剂和疏水性肽的存在下,PNPH 的水解显著增强。
    DOI:
    10.1246/bcsj.56.3857
点击查看最新优质反应信息

文献信息

  • Bioconjugates of Co(III) complexes with Schiff base ligands and cell penetrating peptides: Solid phase synthesis, characterization and antiproliferative activity
    作者:Dariusz Śmiłowicz、Nils Metzler-Nolte
    DOI:10.1016/j.jinorgbio.2020.111041
    日期:2020.5
    tert.-butoxycarbonyl) in axial positions with simultaneous oxidation of Co(II) to Co(III) under ambient environment. All Co(III) complexes were characterized by multinuclear NMR spectroscopy (1H, 13C and 59Co NMR), FT-IR, mass spectrometry and HPLC. The Co(III) complexes were conjugated to three different cell penetrating peptides: FFFF (P1), RRRRRRRRRGAL (P2) and FFFFRRRRRRRRRGAL (P3). Standard solid-phase
    在这项工作中,我们通过水杨醛与3,4-二氨基苯甲酸(1)的单缩合反应合成了一种螯合的席夫碱。该配体在氮气下进一步用于与CoCl2·6H2O络合。在下一步中,通过使该配合物与咪唑(2),2-甲基咪唑(3)和N-Boc-1-组氨酸甲酯(4)配位(Boc:叔。 -丁氧基羰基)在轴向位置,同时在环境中将Co(II)氧化为Co(III)。所有的Co(III)配合物均通过多核NMR光谱(1H,13C和59Co NMR),FT-IR,质谱和HPLC进行表征。Co(III)复合物与三种不同的细胞穿透肽偶联:FFFF(P1),RRRRRRRRRRGAL(P2)和FFFFRRRRRRRRRGAL(P3)。标准固相肽化学用于细胞穿透肽的合成。N末端肽与钴配合物的偶联,在四齿席夫碱配体上具有羧基,提供了Co(III)-肽生物缀合物,其通过半制备HPLC纯化并通过分析HPLC和质谱法表征。与顺铂作为参考药物的活性相
  • Copper‐Promoted O‐Arylation of the Phenol Side Chain of Tyrosine Using Triarylbismuthines
    作者:Adrien Le Roch、Martin Hébert、Alexandre Gagnon
    DOI:10.1002/ejoc.202000790
    日期:2020.9.7
    for the O‐arylation of the side chain of tyrosine using triarylbismuth reagents is reported. The reaction is performed in dichloromethane under oxygen at 50 °C in the presence of pyridine, is promoted by copper diacetate, shows excellent scope and functional group tolerance, and retains the integrity of the chiral center. The reactivity of other amino acids possessing a nucleophilic side chain under these
    报道了使用三芳基铋试剂对酪氨酸侧链进行O-芳基化的方法。该反应在吡啶存在下于氧气中于50°C的氧气中于二氯甲烷中进行,由二乙酸铜促进,显示出极好的范围和官能团耐受性,并保留了手性中心的完整性。研究了在这些条件下具有亲核侧链的其他氨基酸的反应性。可以实现含酪氨酸的二肽和三肽的O-酰化。
  • Bioorthogonal Ligation and Cleavage by Reactions of Chloroquinoxalines with <i>ortho</i> ‐Dithiophenols
    作者:Youshan Li、Zhenbang Lou、Hongyun Li、Haijun Yang、Yufen Zhao、Hua Fu
    DOI:10.1002/anie.201913620
    日期:2020.2.24
    CQ-DT bioorthogonal reactions can be applied for the bioorthogonal ligations, bioorthogonal cleavages, and trans-tagging of proteins, and show advantages of readily accessible unnatural orthogonal groups, appealing reaction kinetics (k2 ≈1.3 m-1  s-1 ), excellent biocompatibility of orthogonal groups, and high stability of conjugates. This complements previous bioorthogonal reactions and is a new route
    提出了一种通过氯喹喔啉(CQ)和邻二硫代苯酚(DT)反应的生物正交连接和裂解方法。邻二硫代苯酚对氯喹喔啉的双亲核取代提供了包含四环苯并[5,6] [1,4]二噻吩并[2,3-b]喹喔啉的结合物,该结合物具有强大的内置荧光并释放了其他功能分子。设计了三个可裂解的接头,并成功地用于从蛋白质结合物中释放出含有生物素的分子。CQ-DT生物正交反应可用于蛋白质的生物正交连接,生物正交切割和反式标记,并显示出易于获得的非天然正交基团的优势,具有吸引人的反应动力学(k2≈1.​​3m-1 s-1),非常好正交基团的生物相容性和结合物的高稳定性。
  • Indium(III) Halides as New and Highly Efficient Catalysts for <i>N</i>-<i>tert</i>-Butoxycarbonylation of Amines
    作者:Asit Chakraborti、Sunay Chankeshwara
    DOI:10.1055/s-2006-942492
    日期:2006.8
    Indium(III) bromide and chloride efficiently catalysed the N-tert-butoxycarbonylation of amines with (Boc)2O at room temperature and under solvent-free conditions. Various aromatic, heteroaromatic and aliphatic amines were converted to N-tert-butylcarbamates in excellent yields in short times. Chiral amines, esters of α-amino acids and β-amino alcohols afforded optically pure N-t-Boc derivatives in high yields. The reactions were chemoselective and no competitive side reactions such as isocyanate, urea, and N,N-di-t-Boc formation were observed. Chemoselective conversion to N-tert-butylcarbamates took place with amino alcohols without any formation of oxazolidinones.
    溴化铟(III)和氯化铟(III)在室温下以及无溶剂条件下有效地催化胺类与(Boc)2O的N-叔丁氧羰基化反应。多种芳香、杂芳香和脂肪胺类在短时间内高效转化为N-叔丁基氨基甲酸酯。手性胺、α-氨基酸酯和β-氨基醇在较高产率下得到光学纯的N-t-Boc衍生物。反应具有化学选择性,未观察到异氰酸酯、脲和N,N-二-t-Boc形成等竞争性副反应。氨基醇也能进行化学选择性转化为N-叔丁基氨基甲酸酯,而不形成噁唑烷酮。
  • Amino-oxetanes as amide isosteres by an alternative defluorosulfonylative coupling of sulfonyl fluorides
    作者:Juan J. Rojas、Rosemary A. Croft、Alistair J. Sterling、Edward L. Briggs、Daniele Antermite、Daniel C. Schmitt、Luka Blagojevic、Peter Haycock、Andrew J. P. White、Fernanda Duarte、Chulho Choi、James J. Mousseau、James A. Bull
    DOI:10.1038/s41557-021-00856-2
    日期:2022.2
    This disconnection, comparable to a typical amidation, will allow the application of vast existing amine libraries. The reaction is tolerant to a wide range of polar functionalities and is suitable for array formats. Ten oxetane analogues of bioactive benzamides and marketed drugs are prepared. Kinetic and computational studies support the formation of an oxetane carbocation as the rate-determining
    生物等排体提供了有价值的设计元素,药物化学家可以使用这些元素将生物活性化合物的结构和药代动力学特征调整为可行的候选药物。芳基氧杂环丁胺作为苯甲酰胺(非常常见的药效团)的生物等排体具有令人兴奋的潜力,但由于缺乏可用的合成方法而很少被检查。在这里,我们描述了磺酰氟通过已建立的 SuFEx(磺酰氟交换)点击反应性的替代途径形成氨基氧杂环丁烷的一类反应。脱氟磺酰化仅在加热时形成平面氧杂环丁烷碳正离子。这种断开与典型的酰胺化相当,将允许应用大量现有的胺库。该反应对多种极性官能团具有耐受性,适用于阵列形式。制备了十种具有生物活性的苯甲酰胺和已上市药物的氧杂环丁烷类似物。动力学和计算研究支持氧杂环丁烷碳正离子的形成作为速率决定步骤,然后是化学选择性亲核偶联步骤。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物